NK-Activity Characterized PBMC

PBMC from normal, healthy donors were screened for NK activity using the CTL TVA™ Platform, and the percentage of killing is shown for K562 tumor cells. PBMC samples were incubated at different ratios of Effector Cells (PBMC containing NK cells) to Target Cells (K562 tumor cells labeled with fluorescent TVA™ Dye.) Following a four hour incubation period, the remaining labeled Target Cells were counted using the ImmunoSpot® TVA™ Platform, and the percentage of killing at each ratio was determined. The resulting killing curves are shown below.

More about the CTL NK-TVA™ Platform

LP_123
LP_123
LP_133
LP_133
LP_108
LP_108
 
LP_180
LP_180
LP_140
LP_140
LP_184
LP_184
 
LP_132
LP_132
LP_188
LP_188
LP_113
LP_113
 
LP_191
LP_191
LP_20
LP_20
LP_98
LP_98
 
LP_162
LP_162
LP_154
LP_154
LP_88
LP_88
 
LP_65
LP_65
LP_56
LP_56
LP_82
LP_82
 
LP_105
LP_105
LP_149
LP_149
LP_142
LP_142
 
LP_158
LP_158
LP_181
LP_181
LP_116
LP_116
 
LP_78
LP_78
LP_161
LP_161
LP_119
LP_119
 
LP_96
LP_96
LP_73
LP_73
LP_77
LP_77
 
LP_194
LP_194
LP_99
LP_99
LP_11
LP_11
 
LP_126
LP_126
LP_121
LP_121
LP_50
LP_50
 
LP_7
LP_7
LP_157
LP_157
LP_182
LP_182
 
LP_70
LP_70
LP_92
LP_92
LP_141
LP_141
 
LP_115
LP_115
LP_81
LP_81
LP_147
LP_147
 
LP_151
LP_151
LP_316
LP_316
LP_317
LP_317
 
LP_322
LP_322
LP_327
LP_327
LP_328
LP_328
 
LP_331
LP_331
LP_333
LP_333
LP_334
LP_334
 
LP_337
LP_337
LP_339
LP_339